Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial.
Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, Il'Giovine ZJ, Mehra R, McWilliams C, Nissen SE, Desai MY. Thomas S, et al. Among authors: patel d. JAMA Netw Open. 2021 Feb 1;4(2):e210369. doi: 10.1001/jamanetworkopen.2021.0369. JAMA Netw Open. 2021. PMID: 33576820 Free PMC article. Clinical Trial.
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial.
Kumar A, Patel DR, Wolski KE, Lincoff AM, Kashyap SR, Ruotolo G, McErlean E, Weerakkody G, Riesmeyer JS, Nicholls SJ, Nissen SE, Menon V. Kumar A, et al. Diab Vasc Dis Res. 2019 Mar;16(2):171-177. doi: 10.1177/1479164119827604. Diab Vasc Dis Res. 2019. PMID: 31014095 Free article.
Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial.
Kumar A, Patel DR, Brennan DM, Wolski KE, Lincoff AM, Ruotolo G, McErlean E, Weerakkody G, Riesmeyer JS, Nicholls SJ, Nissen SE, Menon V. Kumar A, et al. J Am Heart Assoc. 2019 Dec 3;8(23):e013790. doi: 10.1161/JAHA.119.013790. Epub 2019 Nov 22. J Am Heart Assoc. 2019. PMID: 31752637 Free PMC article. Clinical Trial.
Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V, Kumar A, Patel DR, John JS, Wolski KE, McErlean E, Riesmeyer JS, Weerakkody G, Ruotolo G, Cremer PC, Nicholls SJ, Lincoff AM, Nissen SE. Menon V, et al. J Am Heart Assoc. 2020 Jan 7;9(1):e014328. doi: 10.1161/JAHA.119.014328. Epub 2019 Dec 19. J Am Heart Assoc. 2020. PMID: 31852422 Free PMC article. Clinical Trial.
Predictors of long-term outcomes greater than 10 years after cardiac resynchronization therapy implantation.
Patel D, Trulock KM, Moennich LA, Kiehl EL, Kumar A, Toro S, Donnellan E, Grimaldi A, Baranowski B, Hussein AA, Tarakji KG, Cantillon DJ, Niebauer M, Wazni OM, Varma N, Wilkoff BL, Rickard JW. Patel D, et al. J Cardiovasc Electrophysiol. 2020 May;31(5):1182-1186. doi: 10.1111/jce.14425. Epub 2020 Mar 15. J Cardiovasc Electrophysiol. 2020. PMID: 32108406
Cardiac troponin testing: Goodbye, 'troponinemia'.
Kumar A, Patel DR, Menon V. Kumar A, et al. Cleve Clin J Med. 2020 Jul 31;87(8):483-484. doi: 10.3949/ccjm.87a.20013. Cleve Clin J Med. 2020. PMID: 32737048 Free article. No abstract available.
6,438 results